Vivos Therapeutics Announces 1-for-25 Reverse Stock Split, Effective Oct. 27
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has announced a 1-for-25 reverse stock split, which will be effective from October 27. This move is typically aimed at increasing the per-share price of the company's stock.
October 26, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Vivos Therapeutics' 1-for-25 reverse stock split may lead to an increase in the per-share price of the company's stock.
A reverse stock split reduces the number of shares in circulation, which can lead to an increase in the per-share price. However, it does not change the overall market capitalization of the company. The impact on the stock price can be neutral in the short term as the market adjusts to the new share count and price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100